These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. Waxman DJ. J Endocrinol; 1996 Sep; 150 Suppl():S129-47. PubMed ID: 8943797 [Abstract] [Full Text] [Related]
26. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium. Neumannova M, Kauppila A, Vihko R. Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973 [Abstract] [Full Text] [Related]
27. A correlation between estrogen sulfotransferase levels and estrogen receptor status in human primary breast carcinoma. Adams JB, Pewnim T, Chandra DP, Archibald L, Foo MS. Cancer Res; 1979 Dec; 39(12):5124-6. PubMed ID: 498139 [Abstract] [Full Text] [Related]
30. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Maggiolini M, Donzé O, Jeannin E, Andò S, Picard D. Cancer Res; 1999 Oct 01; 59(19):4864-9. PubMed ID: 10519397 [Abstract] [Full Text] [Related]
32. Biochemical correlates of morphologic differentiation in human breast cancer. Silva JS, Cox CE, Wells SA, Paull D, Dilley WG, McCarty KS, Fetter BF, Glaubitz LC, McCarty KS. Surgery; 1982 Sep 01; 92(3):443-9. PubMed ID: 7202259 [Abstract] [Full Text] [Related]
33. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer. Romić-Stojković R, Gamulin S. Cancer Res; 1980 Dec 01; 40(12):4821-5. PubMed ID: 7438115 [Abstract] [Full Text] [Related]
34. Detection and measurement of alpha-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride. Sarcione EJ, Zloty M, Delluomo DS, Mizejewski G, Jacobson H. Cancer Res; 1983 Aug 01; 43(8):3739-41. PubMed ID: 6190555 [Abstract] [Full Text] [Related]
35. [Incidence and importance of nuclear estradiol receptors in human breast cancer]. Dietrich W. Arch Geschwulstforsch; 1982 Aug 01; 52(8):667-83. PubMed ID: 6762860 [Abstract] [Full Text] [Related]
36. Liquid chromatography-mass spectrometric assay of androstenediol in prostatic tissue: influence of androgen deprivation therapy on its level. Higashi T, Takayama N, Kyutoku M, Shimada K, Koh E, Namiki M. Steroids; 2006 Nov 01; 71(11-12):1007-13. PubMed ID: 16978674 [Abstract] [Full Text] [Related]
37. Uptake and concentration of steroid hormones in mammary tissues. Thijssen JH, van Landeghem AA, Poortman J. Ann N Y Acad Sci; 1986 Nov 01; 464():106-16. PubMed ID: 2942072 [Abstract] [Full Text] [Related]
38. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma. Pewnim T, Adams JB, Ho KP. Cancer Res; 1980 Apr 01; 40(4):1360-2. PubMed ID: 6928401 [Abstract] [Full Text] [Related]
39. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas. Holt JA, Lyttle CR, Lorincz MA, Stern SD, Press MF, Herbst AL. J Natl Cancer Inst; 1981 Aug 01; 67(2):307-18. PubMed ID: 6943370 [Abstract] [Full Text] [Related]
40. Estradiol receptor levels in human breast carcinomas. Bird CE, Houghton B, Westenbrink W, Tenniswood M, Sterns EE, Clark AF. Can Med Assoc J; 1981 Apr 15; 124(8):1010-2. PubMed ID: 7260784 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]